TY  - CONF
ID  - AA02022
T1  - Comparison of MR preprocessing strategies and sequences for radiomics-based MGMT prediction
A1  - Abler, Daniel
A1  - Andrearczyk, Vincent
A1  - Oreiller, Valentin
A1  - Barranco Garcia, Javier
A1  - Vuong, Diem
A1  - Tanadini-Lang, Stephanie
A1  - Guckenberger, Matthias
A1  - Reyes, Mauricio
A1  - Depeursinge, Adrien
ED  - Crimi, Alessandro
ED  - Bakas, Spyridon
TI  - Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries (MICCAI/BrainLes 2021)
T3  - LNCS
Y1  - 2022
VL  - 12963
SP  - 367–380
PB  - Springer International Publishing
CY  - Cham
SN  - 978-3-031-09002-8
M2  - doi: 10.1007/978-3-031-09002-8_33
N2  - Hypermethylation of the O6-methylguanine-DNA-methyltransferase (MGMT) promoter in glioblastoma (GBM) is a predictive biomarker associated with improved treatment outcome. In clinical practice, MGMT methylation status is determined by biopsy or after surgical removal of the tumor. This study aims to investigate the feasibility of non-invasive medical imaging based “radio-genomic” surrogate markers of MGMT methylation status.
ER  -